How To Cite
Sheikholeslami
H, Ziaee
A, Darvishghaderi
S, Vahedi
S. Hypothyroidism and type 1 diabetes mellitus. J Inflamm Dis. 2007;11(3):e155344.
Abstract
Abstract
Background: Type 1 diabetes mellitus is frequently associated with autoimmune thyroid disease. Genetic susceptibility to autoantibody formation in association with autoimmune thyroid disease and type 1 diabetes mellitus has been described with varying frequencies.
Objective: To investigate the prevalence of anti-thyroid peroxidase (anti-TPO) and also the overt and subclinical hypothyroidism in type 1 diabetic patients.
Methods: In this case-control study, 65 subjects with type 1 diabetes mellitus and 65 unrelated normal controls were recruited for detection of anti-TPO and thyroid-stimulating hormone (TSH). Radioimmunoassay (RIA) was used for anti-TPO and TSH detection.
Findings: Out of 65 type 1 diabetic patients, 18 (27.7%) were positive for anti-TPO and 18 (27.7%) with abnormal serum TSH level. Among the patient group, 11 (16%) were found to have overt hypothyroidism and 7 (10.8%) with subclinical hypothyroidism. The mean anti-TPO levels were higher in patients with overt hypothyroidism (238.18±223.69 U/ml) than in patients with subclinical hypothyroidism (36.38±22.46 U/ml). Of a total of 11 patients with overt hypothyroidism, 9 (81.1%) showed abnormal anti-TPO levels, whereas positive anti-TPO was detected in 57% (4 out of 7) of patients with subclinical hypothyroidism.
Conclusion: The presence of anti-TPO in 27.7% of type 1 diabetic patients confirmed a strong association between autoimmune thyroid disease and type 1 diabetes mellitus. Thus, for early detection of autoimmune thyroid disease in patients with type 1 diabetes mellitus, the measurement of anti-TPO and TSH, preferably at the onset of disease, is recommended.
We use cookies to provide you with the best possible experience. They also allow us to analyze user behavior in order to constantly improve the website for you.